R Squared’s Sana Biotechnology SANA Stock Holding History

R Squared’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,600	Closed	-$4.24K	–	1267
2024 Q4	$4.24K	Buy	+2,600	New	+$7.75K	﹤0.01%	1350

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

R Squared's SANA Position: Q1 2025 in Review

R Squared sold out of Sana Biotechnology (SANA) in Q1 2025, closing a stake of 2,600 shares — an estimated $4.24K sold.

R Squared first reported a position in SANA in Q4 2024 and held it in 1 quarter. The position peaked at $4.24K in Q4 2024. 161 funds tracked by Wall St. Rank hold SANA as of Q1 2025.

R Squared reported no remaining Sana Biotechnology position as of Q1 2025 after selling out during the quarter.
R Squared sold 2,600 Sana Biotechnology shares in Q1 2025, an estimated $4.24K.
R Squared first reported a position in Sana Biotechnology in Q4 2024 and held it in 1 quarter.
R Squared's Sana Biotechnology position peaked at $4.24K in Q4 2024.
161 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.